VIMTA LABS
Quarterly Results Analysis [Jun2026]
VIMTA LABS Quarterly Results
| Standalone | Jun2026 UnAudited |
Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹109 Cr | ₹109 Cr | ₹99 Cr | ₹102 Cr | ₹98 Cr | ₹94 Cr | ₹90 Cr | ₹85 Cr |
| Expenses | ₹72 Cr | ₹70 Cr | ₹64 Cr | ₹68 Cr | ₹64 Cr | ₹61 Cr | ₹57 Cr | ₹55 Cr |
| Operating Income | ₹37 Cr | ₹39 Cr | ₹34 Cr | ₹34 Cr | ₹34 Cr | ₹33 Cr | ₹33 Cr | ₹30 Cr |
| Other Income | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr |
| Depreciation | ₹13 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹10 Cr | ₹8 Cr |
| Profit Before Tax | ₹28 Cr | ₹29 Cr | ₹23 Cr | ₹26 Cr | ₹25 Cr | ₹25 Cr | ₹24 Cr | ₹22 Cr |
| Profit After Tax | ₹21 Cr | ₹21 Cr | ₹18 Cr | ₹20 Cr | ₹19 Cr | ₹18 Cr | ₹18 Cr | ₹17 Cr |
| EPS | ₹4.71 | ₹4.73 | ₹3.94 | ₹4.47 | ₹4.25 | ₹4.12 | ₹3.94 | ₹3.84 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| VIMTA LABS | 0.7% | -1.2% | 23.4% |
| SAGILITY | -1% | 3.3% | -9.5% |
| SYNGENE INTERNATIONAL | -3.5% | -7.6% | -39.1% |
| PRIME FOCUS | -1.2% | 34.2% | 63.5% |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | -0.2% | -2.6% | -12.3% |
| INDEGENE | -4.2% | -7.8% | -15% |
| NESCO | -4.1% | -6% | -17.6% |
| LATENT VIEW ANALYTICS | -3.4% | 0.5% | -29.3% |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -8.9% | -8.9% | 31.1% |
VIMTA LABS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | -0.16 % |
| Y-o-Y | 11.80 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2026 | ₹109 Cr | -0.16 | |
| Mar2026 | ₹109 Cr | 10.76 | |
| Dec2025 | ₹99 Cr | -3.16 | |
| Sep2025 | ₹102 Cr | 4.39 | |
| Jun2025 | ₹98 Cr | 3.31 | |
| Mar2025 | ₹94 Cr | 5.02 | |
| Dec2024 | ₹90 Cr | 6.11 | |
| Sep2024 | ₹85 Cr | - | |
VIMTA LABS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -5.23 % |
| Y-o-Y | 10.75 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2026 | ₹37 Cr | -5.23 | |
| Mar2026 | ₹39 Cr | 15.00 | |
| Dec2025 | ₹34 Cr | 0.01 | |
| Sep2025 | ₹34 Cr | 1.60 | |
| Jun2025 | ₹34 Cr | 1.98 | |
| Mar2025 | ₹33 Cr | -0.14 | |
| Dec2024 | ₹33 Cr | 10.64 | |
| Sep2024 | ₹30 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -5.08 % |
| Y-o-Y | -0.93 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2026 | 34.21% | -5.08 | |
| Mar2026 | 36.04% | 3.83 | |
| Dec2025 | 34.71% | 3.27 | |
| Sep2025 | 33.61% | -2.66 | |
| Jun2025 | 34.53% | -1.29 | |
| Mar2025 | 34.98% | -4.92 | |
| Dec2024 | 36.79% | 4.28 | |
| Sep2024 | 35.28% | - | |
VIMTA LABS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -0.34 % |
| Y-o-Y | 11.37 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2026 | ₹21 Cr | -0.34 | |
| Mar2026 | ₹21 Cr | 20.06 | |
| Dec2025 | ₹18 Cr | -11.72 | |
| Sep2025 | ₹20 Cr | 5.43 | |
| Jun2025 | ₹19 Cr | 3.14 | |
| Mar2025 | ₹18 Cr | 4.58 | |
| Dec2024 | ₹18 Cr | 2.94 | |
| Sep2024 | ₹17 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -0.21 % |
| Y-o-Y | -0.41 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2026 | 19.29 % | -0.21 | |
| Mar2026 | 19.33 % | 8.41 | |
| Dec2025 | 17.83 % | -8.84 | |
| Sep2025 | 19.56 % | 0.98 | |
| Jun2025 | 19.37 % | -0.15 | |
| Mar2025 | 19.4 % | -0.41 | |
| Dec2024 | 19.48 % | -2.99 | |
| Sep2024 | 20.08 % | - | |
VIMTA LABS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -0.42 % |
| Y-o-Y | 10.82 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2026 | ₹4.71 | -0.42 | |
| Mar2026 | ₹4.73 | 20.05 | |
| Dec2025 | ₹3.94 | -11.86 | |
| Sep2025 | ₹4.47 | 5.18 | |
| Jun2025 | ₹4.25 | 3.16 | |
| Mar2025 | ₹4.12 | 4.57 | |
| Dec2024 | ₹3.94 | 2.60 | |
| Sep2024 | ₹3.84 | - | |
You may also like the below Video Courses
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs NESCO LTD